Novacta Biosystems Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Novacta Biosystems General Information

Description

Provider of a clinical stage bio-pharmaceutical services intended to treat bacterial infections. The company's clinical stage bio-pharmaceutical services include discovery, development and commercialization of novel class small peptide molecules called lantibiotics for the treatment of bacterial infections, especially those caused by drug resistant bacteria and for the treatment of Clostridium difficile infection, providing users with anti-infectives and an infectious disease therapeutic pipeline.

Contact Information

Website
www.novactabio.com
Formerly Known As
Legislator 1509 Limited
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • BioPark Hertfordshire
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England, United Kingdom
+44 01707
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • BioPark Hertfordshire
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England, United Kingdom
+44 01707

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novacta Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 28-Apr-2016 Completed Bankruptcy: Liquidation
3. Early Stage VC 06-Jul-2009 Completed Generating Revenue
2. Grant 14-Jan-2008 $6.93M $859K Completed Generating Revenue
1. Early Stage VC 07-Aug-2007 $859K $859K Completed Generating Revenue
To view Novacta Biosystems’s complete valuation and funding history, request access »

Novacta Biosystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary-A
To view Novacta Biosystems’s complete cap table history, request access »

Novacta Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a clinical stage bio-pharmaceutical services intended to treat bacterial infections. The company's clinical
Drug Discovery
Welwyn Garden City, United Kingdom
51 As of 2016

Cambridge, MA
 

Macclesfield, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novacta Biosystems Competitors (51)

One of Novacta Biosystems’s 51 competitors is Spero Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spero Therapeutics Formerly VC-backed Cambridge, MA
F2G Venture Capital-Backed Macclesfield, United Kingdom
Gilead Formerly VC-backed Foster City, CA
Gossamer Bio Formerly VC-backed San Diego, CA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 5 of 51 competitors. Get the full list »

Novacta Biosystems Patents

  • 104

    Total Documents Applications and Grants

  • Total Patents Families

  • 24

    Granted

  • Pending

  • Expiring in next 12 mo

Novacta Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201213434-D0 The use of type-b lantibiotic-based compounds having antimicrobial activity Inactive 27-Jul-2012
WO-2014016613-A2 The use of type-b lantibiotic-based compounds having antimicrobial activity Inactive 27-Jul-2012
WO-2014016613-A3 Type b lantibiotic nvb302 for the treatment of c. difficile infection Inactive 27-Jul-2012
US-20150031602-A1 Compounds Active 18-Nov-2011
US-9234006-B2 Compounds Active 18-Nov-2011 C07K7/62
To view Novacta Biosystems’s complete patent history, request access »

Novacta Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novacta Biosystems Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Iceni Capital PE/Buyout Minority
To view Novacta Biosystems’s complete investors history, request access »

Ready to get started?

Request a free trial

Novacta Biosystems FAQs

  • When was Novacta Biosystems founded?

    Novacta Biosystems was founded in 2000.

  • Where is Novacta Biosystems headquartered?

    Novacta Biosystems is headquartered in Welwyn Garden City, United Kingdom.

  • What is the size of Novacta Biosystems?

    Novacta Biosystems has 51 total employees.

  • What industry is Novacta Biosystems in?

    Novacta Biosystems’s primary industry is Drug Discovery.

  • Is Novacta Biosystems a private or public company?

    Novacta Biosystems is a Private company.

  • What is Novacta Biosystems’s current revenue?

    The current revenue for Novacta Biosystems is .

  • How much funding has Novacta Biosystems raised over time?

    Novacta Biosystems has raised $22.3M.

  • Who are Novacta Biosystems’s investors?

    Iceni Capital has invested in Novacta Biosystems.

  • Who are Novacta Biosystems’s competitors?

    Spero Therapeutics, F2G, Gilead, Gossamer Bio, and Ability Pharma are some of the 51 competitors of Novacta Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process